| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 12/28/2006 | WO2006137258A1 Pharmaceutical composition comprising azarhodacyanine compound as active ingredient |
| 12/28/2006 | WO2006137092A1 Fluorescent sulfonamide derivatives having carbonic anhydrase inhibiting activity and their use as theapeutic and diagnostic agents |
| 12/28/2006 | WO2006137019A1 Novel thiophene derivatives |
| 12/28/2006 | WO2006137009A2 Fluorescent sulfonamide derivatives having carbonic anhydrase inhibiting activity and their use as therapeutic and diagnostic agents |
| 12/28/2006 | WO2006136924A1 Histamine-3 receptor antagonists |
| 12/28/2006 | WO2006136245A1 Substituted spiro-compounds and the use thereof for producing medicaments |
| 12/28/2006 | WO2006122014A3 Bicyclic derivatives as modulators of ion channels |
| 12/28/2006 | WO2006060381A3 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| 12/28/2006 | WO2006058648A3 Biaryloxymethylarene carboxylic acids |
| 12/28/2006 | WO2005087752A8 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 12/28/2006 | WO2005080358A3 Rosiglitazone phosphate and polymorphic forms |
| 12/28/2006 | US20060293527 Analogs of epothilone |
| 12/28/2006 | US20060293519 Method for producing cyclic diamine derivative or salt thereof |
| 12/28/2006 | US20060293374 Substituted isothiazolones |
| 12/28/2006 | US20060293373 Gamma-secretase inhibitors |
| 12/28/2006 | US20060293366 Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors |
| 12/28/2006 | US20060293365 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics |
| 12/28/2006 | US20060293341 Alkyl sulfonamide derivatives |
| 12/28/2006 | US20060293340 2-Aminopyrimidine derivatives as raf kinase inhibitors |
| 12/28/2006 | US20060293338 protein serine/threonine kinase inhibitors such as 2-(2-Chloro-5-fluoro-phenylimino)-5-(2,3-dihydro-benzo[1-6]dioxin-6-ylmethylene)-thiazolidin-4-one, used for treating autoimmune diseases, HIV, cancer, anemia myelodysplastic syndrome and thrombocytopenia |
| 12/28/2006 | US20060293337 P2x7 receptor antagonists and their use |
| 12/28/2006 | US20060293336 C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 12/28/2006 | US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase |
| 12/28/2006 | US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 12/28/2006 | US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/28/2006 | US20060293320 Heteroaryl derivatives for treating viruses |
| 12/28/2006 | US20060293315 Intermediates of novel heterocyclic compounds having antibacterial activity and process for their preparation |
| 12/28/2006 | US20060293314 4- Piridinylmethylsulphonamide derivatives as fungicidal plant protein agents |
| 12/28/2006 | US20060293313 Indole-3-alkyl-N-piperazine ring substituted with quinoline ring or derivatives; shows high affinity for both the dopamine D2 receptor and the serotonin reuptake site, useful for treating central nervous system disorders, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia |
| 12/28/2006 | US20060293311 Compositions and methods for inhibition of the jak pathway |
| 12/28/2006 | US20060293310 Derivatives of 1-piperazine-and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme |
| 12/28/2006 | US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 12/28/2006 | US20060293303 e.g. 2-(4-Fluorophenyl)-7-(1-methylpiperidin-4-yl)-3-(2-methylpyrimidin-4-yl)imidazo[1,2-a]-pyridine; protozoal diseases (toxoplasmosis, malaria, African typanosomiasis, Chagas disease, and opportunistic infections) in mammals and birds; controlling coccidiosis in poultry |
| 12/28/2006 | US20060293300 New substituted thiophene carboxamides, process for their preparation and their use as medicaments |
| 12/28/2006 | US20060293281 N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 12/28/2006 | CA2612661A1 Novel thiophene derivatives |
| 12/28/2006 | CA2612105A1 Chemokine receptor binding compounds |
| 12/28/2006 | CA2608319A1 Substituted spiro-compounds and the use thereof for producing medicaments |
| 12/27/2006 | EP1736474A1 Piperidine derivative |
| 12/27/2006 | EP1736468A2 Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation |
| 12/27/2006 | EP1736467A1 Novel sulfonamide derivative |
| 12/27/2006 | EP1735622A2 Modulators of human g protein-coupled receptors for the treatment of hyperglycemia and related disorders |
| 12/27/2006 | EP1735319A1 Inhibitors of histone deacetylase |
| 12/27/2006 | EP1735307A1 Inhibitors of iap |
| 12/27/2006 | EP1735303A2 1,3,4-oxadiazol-2-ones as ppar delta modulators and their use thereof |
| 12/27/2006 | EP1735302A1 4-amino-piperidine derivatives as monoamine uptake inhibitors |
| 12/27/2006 | EP1735293A2 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 12/27/2006 | EP1735291A2 Rosiglitazone phosphate and polymorphic forms |
| 12/27/2006 | EP1735288A1 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders |
| 12/27/2006 | EP1735284A1 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides |
| 12/27/2006 | EP1735280A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders |
| 12/27/2006 | EP1735275A2 Aryl sulfones and uses related thereto |
| 12/27/2006 | EP1734966A2 Piperizinylpiperidine derivatives as chemokine receptor antagonists |
| 12/27/2006 | EP1734957A2 Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders |
| 12/27/2006 | EP1608317A4 Dipeptidyl peptidase inhibitors |
| 12/27/2006 | EP1558255B1 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease |
| 12/27/2006 | EP1471786B1 Microbiocidal n-phenyl-n- 4-(4-pyridyl)-2-pyrimidin-2-yl|-amine derivatives |
| 12/27/2006 | EP1448559B1 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient |
| 12/27/2006 | EP1430051B1 N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-n-phenylamines as antiproliferative compounds |
| 12/27/2006 | EP1427423B1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 12/27/2006 | EP1358144B1 Epothilone synthesis components i: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone and epothilone derivatives |
| 12/27/2006 | EP1187826B1 Heterocyclic derivatives useful as anticancer agents |
| 12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
| 12/27/2006 | CN1886403A Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas |
| 12/27/2006 | CN1886391A Tetronic and tetramic acids as inhibitors of beta-secrease |
| 12/27/2006 | CN1886386A Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 12/27/2006 | CN1886381A Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 12/27/2006 | CN1886378A 1,4-disubstituted isoquinilone derivatives as RAF-kinase inhibitors useful for the treatment of proliferative diseases |
| 12/27/2006 | CN1886372A 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions |
| 12/27/2006 | CN1291985C Neurotrophin production/secretion promoting agent |
| 12/27/2006 | CN1291983C Luminescent element material and luminescent element comprising the same |
| 12/26/2006 | US7153968 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease, eosinophilic granuloma, psoriasis and other benign or malignant proliferative skin diseases, endotoxic shock, laminitis in horses, colic in horses, septic shock, ulcerative colitis, Crohn's disease, reperfusion injury |
| 12/26/2006 | US7153964 Pyrimidine compounds |
| 12/26/2006 | US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 12/26/2006 | US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 12/26/2006 | US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics |
| 12/26/2006 | US7153883 Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
| 12/26/2006 | US7153879 E.g., 7,11-Di(hydroxy)-8,8,10,12,16-pentamethyl-3-(1-methyl-2-(methylthiazol-4-yl)ethenyl)-4-aza-17-oxabicyclo(14.1.0)heptadecane-5,9-dione, preferably Form A; anticarcinogenic, -proliferative, -diabetic, -inflammatory agents; viricides; autoimmune diseases; psoriasis; agents; cardiovascular disorders |
| 12/26/2006 | US7153878 Substituted thiazoles and oxazoles, e.g., 4-{1-[4-[2-(2-Chloro-6-fluoro-phenyl)-ethyl]-2-(4-trifluoromethyl-phenyl)-thiazol-5-yl]-ethylsulfanyl}-2-methyl-phenoxy)-acetic acid; treating atherosclerosis and diabetes and creating Syndrome X |
| 12/26/2006 | US7153875 Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
| 12/26/2006 | US7153874 For therapy and prophylaxis of of disorders mediated in full or in part by metabotropic glutamate receptor 5, including, e.g. acute, traumatic and chronic degenerative processes of the nervous system, such as Alzheimer's disease, senile dementia, Parkinson's disease, Huntington's chorea |
| 12/26/2006 | US7153873 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety |
| 12/26/2006 | US7153872 Cancer and fibrotic diseases |
| 12/26/2006 | US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer |
| 12/26/2006 | US7153815 Insecticide containing hydrazone derivative as the active ingredient and novel hydrazone derivative |
| 12/21/2006 | WO2006135828A2 Trisubstituted amines as phosphodiesterase 4 inhibitors |
| 12/21/2006 | WO2006135536A2 Papillary muscle attachement for left ventricular reduction |
| 12/21/2006 | WO2006134468A1 Substituted arylpyrazoles for use against parasitites |
| 12/21/2006 | WO2006134467A1 N-(pyridin-2-yl)-sulfonamide derivatives |
| 12/21/2006 | WO2006134163A2 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 12/21/2006 | WO2006133946A1 Azab i cyclo [3 . 1 . 0] hexane derivatives as dopamin d3 receptor modulators |
| 12/21/2006 | WO2006092599A3 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 12/21/2006 | WO2006087544A3 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 12/21/2006 | WO2006083673A3 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases |
| 12/21/2006 | WO2005092856A8 Tetrahydrocarbazoles and derivatives |
| 12/21/2006 | WO2005072376A3 Anionic-sweetener-based ionic liquids and methods of use thereof |
| 12/21/2006 | US20060287532 Regiospecific Synthesis of Nicotine Derivatives |
| 12/21/2006 | US20060287379 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 12/21/2006 | US20060287377 Vanilloid receptor 1 (VR 1) antagonists; efficacy; N-(3-Fluoro-4-methoxy-phenyl)-2-(7-nitro-1H-benzimidazol-1-yl)-acetamide, |
| 12/21/2006 | US20060287374 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |